News & Knowledge

2020, 20 February

Van Lanschot Kempen: net profit exceeds €98 million in 2019

Today, Van Lanschot Kempen released its 2019 results.

Read More
2019, 22 February

BioCapital Europe

Kempen is proud sponsor of the BioCapital Europe conference.

Read more
2018, 19 December

J.P. Morgan Healthcare Conference

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

Read more
2018, 29 October

Bohemian Medical Device Summit

For the fifth year in a row Kempen is proud sponsor of the Bohemian Medical Device Summit.

Read more
2018, 13 September

14th International Pharma Licensing Symposium

Kempen is proud to be speaker for the first time at the 14th International Pharma Licensing Symposium (IPLS) that will be held in Montreux on September 19-21, 2018.

Read more
2018, 05 June

Biotech CEO Summit Europe

Kempen is proud sponsor of the Biotech CEO Summit Europe.

Read more
2018, 25 January

3x negotiating management terms with private equity

Kempen supports entrepreneurs and management teams that want to increase the return on equity of their company. The first time many business owners start to think about this metric, is when they contemplate a potential sale of their company and realize return on equity is a key valuation driver.

Read more
2018, 18 January

Bio€quity Europe

Kempen is proud sponsor of the Bio€quity Europe conference.

Read more
2017, 26 October

3x negotiating management terms with private equity

Kempen supports entrepreneurs and management teams that want to sell to-, or team-up with private equity investors. We are often the one who, on behalf of our clients, address a subject of debate in those transactions: management terms. During such negotiations there are several recurring topics, three of them are described

Read more
2021, 15 April

Kempen pushes for further growth of its market position in the Nordics

Kempen Capital Management (Kempen) is pleased to announce the appointment of Thomas Poulsen as Director of Business Development Nordics. Poulsen will focus specifically on servicing banks, wealth managers, and institutional investors within the Nordics countries. With this appointment, Kempen pushes for further growth in Europe.

Read More
2021, 01 April

Kempen introduces fund focused on sustainable farmland

In cooperation with launching customer Stichting Pensioenfonds PostNL, Kempen Capital Management (Kempen) has developed the SDG Farmland Fund. This new investment solution will enable professional investors to focus on global investments in agricultural land, while at the same time providing a significant, concrete contribution to the achievement of Sustainable Development Goals (SDGs) 2, 6, 12, 13, and 15*.

Read More
2021, 01 April

Kempen Capital Management (KCM) has decided the Global Small-cap Strategy has now reached the soft-close status.

The Kempen Global Small-cap Strategy has experienced significant growth in its Assets Under Management (AuM). This has caused a situation where current AuM and projected inflow are within our maximum capacity range.

Read More
2021, 30 March

Stichting Pensioenfonds Koninklijke Cosun chooses Kempen as its fiduciary manager

Today, we announce that Stichting Pensioenfonds Koninklijke Cosun (PF Cosun) has chosen Kempen Capital Management (Kempen) as its fiduciary manager. As of April 1, 2021, Kempen will advise on the total invested capital of PF Cosun.

Read More